Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | March 14, 2012 | March 16, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date March 14, 2012 · Filed March 16, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,187 |
Ending reported balance
After 2012-03-15 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2012-03-14 · Exercise / conversion · Acquired 46,856 · Balance 70,043 Row 2 · 2012-03-14 · Exercise / conversion · Acquired 46,849 · Balance 116,892 Row 3 · 2012-03-14 · Sale · Disposed 46,856 · Balance 70,036 F1: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.12 and $45.16 per share. Row 4 · 2012-03-14 · Sale · Disposed 46,849 · Balance 23,187 F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.16 and $45.19 per share. Row 5 · 2012-03-15 · Exercise / conversion · Acquired 33,726 · Balance 56,913 Row 6 · 2012-03-15 · Exercise / conversion · Acquired 33,739 · Balance 90,652 Row 7 · 2012-03-15 · Sale · Disposed 33,726 · Balance 56,926 F3: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.09 and $45.18 per share. Row 8 · 2012-03-15 · Sale · Disposed 33,739 · Balance 23,187 F4: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.09 and $45.18 per share. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $13.41 · Expires 2014-01-02 | Direct | 0 |
Reported balance
After 2012-03-14 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2012-03-14 · Exercise / conversion · Disposed 46,856 · Balance 0 F5: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $9.17 · Expires 2013-02-25 | Direct | 0 |
Reported balance
After 2012-03-14 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2012-03-14 · Exercise / conversion · Disposed 46,849 · Balance 0 F5: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $27.12 · Expires 2016-03-01 | Direct | 0 |
Reported balance
After 2012-03-15 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2012-03-15 · Exercise / conversion · Disposed 33,726 · Balance 0 F5: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $20.23 · Expires 2015-03-01 | Direct | 0 |
Reported balance
After 2012-03-15 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2012-03-15 · Exercise / conversion · Disposed 33,739 · Balance 0 F5: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. |
| Common StockSEC Table I · non-derivative | IndirectBy Trusts | 1,000 |
Reported balance
Holding disclosure · report date 2012-03-14 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 1,000 |
| Share CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 22,924.6292 |
Reported balance
Holding disclosure · report date 2012-03-14 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 22,924.6292 F6: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.12 and $45.16 per share.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.16 and $45.19 per share.
F3: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.09 and $45.18 per share.
F4: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.09 and $45.18 per share.
F5: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.
F6: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · derivative · entry 13 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 15, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · derivative · entry 12 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 15, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 33,739 | $45.11 | $1,521,966.29 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · nonDerivative · entry 8 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,187 F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.09 and $45.18 per share. Read SEC document |
| March 15, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 33,726 | $45.11 | $1,521,379.86 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · nonDerivative · entry 7 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,926 F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.09 and $45.18 per share. Read SEC document |
| March 15, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 33,739 | $20.23 | $682,539.97 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · nonDerivative · entry 6 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 33,726 | $27.12 | $914,649.12 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · nonDerivative · entry 5 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 46,849 | $0.00 Strike: $9.17 | $0.00 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · derivative · entry 11 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,849 shares Expires 2013-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 14, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 46,856 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · derivative · entry 10 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,856 shares Expires 2014-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 14, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 46,849 | $45.17 | $2,116,169.33 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · nonDerivative · entry 4 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,187 F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.16 and $45.19 per share. Read SEC document |
| March 14, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 46,856 | $45.13 | $2,114,611.28 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · nonDerivative · entry 3 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,036 F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $45.12 and $45.16 per share. Read SEC document |
| March 14, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 46,849 | $9.17 | $429,605.33 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · nonDerivative · entry 2 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2012 Filed Mar 16, 2012 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 46,856 | $13.41 | $628,338.96 |
DisclosureSEC source: 0001127602-12-010932 · form4.xml · nonDerivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2011 Filed Nov 4, 2011 19:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,725.7478 | $35.77 Strike: $0.00 | $97,500.00 |
DisclosureSEC source: 0001127602-11-028652 · form4.xml · derivative · entry 3 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,766.9692 Underlying: Common Stock · 2,725.7478 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 11, 2011 Filed May 13, 2011 20:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,600 | $37.50 Strike: $0.00 | $97,500.00 |
DisclosureSEC source: 0001127602-11-016264 · form4.xml · derivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,913.2642 Underlying: Common Stock · 2,600 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| March 15, 2011 Filed Mar 17, 2011 18:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 1,000 | $33.07 | $33,070.00 |
DisclosureSEC source: 0001127602-11-010563 · form4.xml · nonDerivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trusts Disclosed balance after: 1,000 F1 · shares: These shares are held in separate trusts established for the benefit of the reporting person's children. The reporting person is trustee of the childrens' trusts and disclaims any beneficial ownership of these securities. The filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 04, 2010 Filed Nov 5, 2010 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 3,094.2558 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-027129 · form4.xml · derivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,251.0311 Underlying: Common Stock · 3,094.2558 shares Expires not disclosed F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 12, 2010 Filed May 14, 2010 20:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,684.4714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-014346 · form4.xml · derivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,049.4783 Underlying: Common Stock · 2,684.4714 shares Expires not disclosed F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 04, 2009 Filed Nov 6, 2009 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,697.0954 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-021991 · form4.xml · derivative · entry 2 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,323.2939 Underlying: Common Stock · 2,697.0954 shares Expires not disclosed F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation, at the market price, pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 06, 2009 Filed May 8, 2009 20:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 3,050.6884 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-010978 · form4.xml · derivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,613.7226 Underlying: Common Stock · 3,050.6884 shares Expires not disclosed F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation at the market price pursuant to the 1997 Incentive Compensation plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 05, 2008 Filed Nov 7, 2008 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 3,176.9306 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-008958 · form4.xml · derivative · entry 2 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,176.9306 Underlying: Common Stock · 3,176.9306 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 07, 2008 Filed May 8, 2008 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,347.7005 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000052 · doc.xml · derivative · entry 2 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,347.7005 Underlying: Common Stock · 2,347.7005 shares Expires not disclosed F2 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F3 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| May 07, 2008 Filed May 8, 2008 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 4,000 | $41.53 | $166,120.00 |
DisclosureSEC source: 0000064803-08-000052 · doc.xml · nonDerivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,187 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees. Read SEC document |
| November 07, 2007 Filed Nov 8, 2007 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 438 | $41.64 | $18,238.32 |
DisclosureSEC source: 0000064803-07-000163 · doc.xml · nonDerivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,235 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| November 07, 2007 Filed Nov 15, 2007 21:30 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 390 | $41.64 | $16,239.60 |
DisclosureSEC source: 0000064803-07-000178 · doc.xml · nonDerivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,187 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| June 18, 2007 Filed Jun 19, 2007 20:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 18,494 | $37.30 | $689,826.20 |
DisclosureSEC source: 0000064803-07-000123 · doc.xml · nonDerivative · entry 2 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,797 Read SEC document |
| June 18, 2007 Filed Jun 19, 2007 20:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,700 | $37.29 | $212,553.00 |
DisclosureSEC source: 0000064803-07-000123 · doc.xml · nonDerivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,291 Read SEC document |
| May 09, 2007 Filed May 10, 2007 20:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 7,107 | $38.02 | $270,208.14 |
DisclosureSEC source: 0000064803-07-000096 · doc.xml · nonDerivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,991 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · derivative · entry 6 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,726 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · derivative · entry 5 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,739 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 46,856 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · derivative · entry 4 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,856 Underlying: Common Stock · 46,856 shares Expires 2014-01-02 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 46,849 | $0.00 Strike: $9.17 | $0.00 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · derivative · entry 3 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,849 Underlying: Common Stock · 46,849 shares Expires 2013-02-25 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 11,690 | $34.80 | $406,812.00 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · nonDerivative · entry 2 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,884 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 24,194 | $34.80 | $841,951.20 |
DisclosureSEC source: 0000064803-07-000060 · doc.xml · nonDerivative · entry 1 BANKS EDWIN M · CIK 0001199424 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,194 F1 · price: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.